Literature DB >> 22669053

Role of SPECT/CT in differentiated thyroid cancer.

Tara D Barwick1, Ranju T Dhawan, Valerie Lewington.   

Abstract

Radioiodine scintigraphy and therapy has played a major role in the treatment and follow-up of thyroid cancer patients for decades. Single-photon emission computed tomography/computed tomography in this setting is emerging as a useful tool in accurately localizing sites of pathological uptake and physiological mimics of disease, thus providing more accurate staging prognostic information for risk stratification, which in turn tailors management and follow-up regimes. This review presents the current evidence and potential indications of single-photon emission computed tomography/computed tomography in thyroid cancer.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22669053     DOI： 10.1097/MNM.0b013e3283550257

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


  7 in total

Review 1.  Molecular imaging agents for SPECT (and SPECT/CT).

Authors:  Gopinath Gnanasegaran; James R Ballinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-07       Impact factor: 9.236

2.  Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Authors:  Ka-Kit Wong; Arpit Gandhi; Benjamin L Viglianti; Lorraine M Fig; Domenico Rubello; Milton D Gross
Journal:  World J Radiol       Date:  2016-06-28

Review 3.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

Review 4.  Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.

Authors:  Yan-Li Xue; Zhong-Ling Qiu; Hong-Jun Song; Quan-Yong Luo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-15       Impact factor: 9.236

5.  I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan.

Authors:  Julia V Malamitsi; John T Koutsikos; Stamatia I Giourgouli; Sophia F Zachaki; Theodoros A Pipikos; Fani J Vlachou; Vassilios K Prassopoulos
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

6.  A false-positive I-131 finding of duodenum diverticulum in thyroid cancer evaluation by SPECT/CT: A case report.

Authors:  Rang Wang; Ke Zhou; Qiuping Fan; Haotian Chen; Chengzhong Fan
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

7.  The impact of post-radioiodine therapy SPECT/CT on early risk stratification in differentiated thyroid cancer; a bi-institutional study.

Authors:  Szabina Szujo; Livia Sira; Laszlo Bajnok; Beata Bodis; Ferenc Gyory; Orsolya Nemes; Karoly Rucz; Peter Kenyeres; Zsuzsanna Valkusz; Krisztian Sepp; Erzsebet Schmidt; Zsuszanna Szabo; Sarolta Szekeres; Katalin Zambo; Sandor Barna; Endre V Nagy; Emese Mezosi
Journal:  Oncotarget       Date:  2017-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.